The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection
Abstract
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factorial trial in which 210 patients with pleural infection were randomly assigned to receive one of four study treatments for 3 days: double placebo, intrapleural tissue plasminogen activator (t-PA) and DNase, t-PA and placebo, or DNase and placebo. The primary outcome was the change in pleural opacity, measured as the percentage of the hemithorax occupied by effusion, on chest radiography on day 7 as compared with day 1. Secondary outcomes included referral for surgery, duration of hospital stay, and adverse events. RESULTS: The mean (±SD) change in pleural opacity was greater in the t-PA-DNase group than in the placebo group (-29.5±23.3% vs. -17.2±19.6%; difference, -7.9%; 95% confidence interval [CI], -13.4 to -2.4; P=0.005); the change observed with t-PA alone and with DNase alone (-17.2±24.3 and -14.7±16.4%, respectively) was not significantly different from that observed with placebo. The frequency of surgical referral at 3 months was lower in the t-PA-DNase group than in the placebo group (2 of 48 patients [4%] vs. 8 of 51 patients [16%]; odds ratio for surgical referral, 0.17; 95% CI, 0.03 to 0.87; P=0.03) but was greater in the DNase group (18 of 46 patients [39%]) than in the placebo group (odds ratio, 3.56; 95% CI, 1.30 to 9.75; P=0.01). Combined t-PA-DNase therapy was associated with a reduction in the hospital stay, as compared with placebo (difference, -6.7 days; 95% CI, -12.0 to -1.9; P=0.006); the hospital stay with either agent alone was not significantly different from that with placebo. The frequency of adverse events did not differ significantly among the groups. CONCLUSIONS: Intrapleural t-PA-DNase therapy improved fluid drainage in patients with pleural infection and reduced the frequency of surgical referral and the duration of the hospital stay. Treatment with DNase alone or t-PA alone was ineffective. (Funded by an unrestricted educational grant to the University of Oxford from Roche UK and by others; Current Controlled Trials number, ISRCTN57454527.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection
Maskell, N. A., Davies, C. W. H., Nunn, A. J., Hedley, E. L., Gleeson, F. V., Miller, R., Gabe, R., Rees, G. L., Peto, T. E. A., Woodhead, M. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042473 · Cited by 844
Self-citationIzano, E. A., Amarante, M. A., Kher, W. B., & Kaplan, J. B. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02073-07 · Cited by 553
Munoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., Garcia-Garcia, J. J., & Pallares, R. (2008) · Clinical Infectious Diseases · doi:10.1086/524660 · Cited by 333
Design, analysis and presentation of factorial randomised controlled trials
Montgomery, A. A., Peters, T. J., & Little, P. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-26 · Cited by 318
Thomas, V. C., Thurlow, L. R., Boyle, D., & Hancock, L. E. (2008) · Journal of Bacteriology · doi:10.1128/jb.00314-08 · Cited by 302
Management of pleural space infections: A population-based analysis
Farjah, F., Symons, R. G., Krishnadasan, B., Wood, D. E., & Flum, D. R. (2007) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.09.038 · Cited by 257
Hall-Stoodley, L., Nistico, L., Sambanthamoorthy, K., Dice, B., Nguyen, D., Mershon, W. J., Johnson, C., Hu, F. Z., Stoodley, P., Ehrlich, G. D., et al. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-173 · Cited by 243
Alipour, M., Suntres, Z. E., & Omri, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp165 · Cited by 161
Pathways of Fibrin Turnover of Human Pleural Mesothelial Cells In Vitro
Idell, S., Zwieb, C. W., Kumar, A., Koenig, K. B., & Johnson, A. R. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.4.414 · Cited by 135
Intrapleural Fibrinolytic Agents for Empyema and Complicated Parapneumonic Effusions
Tokuda, Y., Matsushima, D., Stein, G. H., & Miyagi, S. (2006) · CHEST Journal · doi:10.1378/chest.129.3.783 · Cited by 118
DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus
Eckhart, L., Fischer, H., Barken, K. B., Tolker‐Nielsen, T., & Tschachler, E. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07886.x · Cited by 107
Effect of Varidase (Streptodornase) on Biofilm Formed by Pseudomonas aeruginosa
Nemoto, K., Hirota, K., Murakami, K., Taniguti, K., Murata, H., Vidučić, D., & Miyake, Y. (2003) · Chemotherapy · doi:10.1159/000070617 · Cited by 91
Validity and power of tests when groups have been balanced for prognostic factors
Forsythe, A. B. (1987) · Computational Statistics & Data Analysis · doi:10.1016/0167-9473(87)90015-6 · Cited by 53
Statistical comparison of random allocation methods in cancer clinical trials
Hagino, A., Hamada, C., Yoshimura, I., Ohashi, Y., Sakamoto, J., & Nakazato, H. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.004 · Cited by 53
Tissue Plasminogen Activator as an Adjuvant Therapy for Pleural Empyema in Pediatric Patients
Ray, T. L., Berkenbosch, J. W., Russo, P. A., & Tobias, J. D. (2004) · Journal of Intensive Care Medicine · doi:10.1177/0885066603259942 · Cited by 30
Comparison of balanced and random allocation in clinical trials: A simulation study
Rovers, M. M., Straatman, H., & Zielhuis, G. A. (2000) · European Journal of Epidemiology · doi:10.1023/a:1010907912024 · Cited by 14
Cited by
Frontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Kahan, B. C., Jairath, V., Doré, C. J., & Morris, T. P. (2014) · Trials · doi:10.1186/1745-6215-15-139 · Cited by 497
Self-citationImproper analysis of trials randomised using stratified blocks or minimisation
Kahan, B. C., & Morris, T. P. (2012) · Statistics in Medicine · doi:10.1002/sim.4431 · Cited by 332
Self-citationFeller-Kopman, D., & Light, R. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1403503 · Cited by 329
ERS/EACTS statement on the management of malignant pleural effusions
Bibby, A. C., Dorn, P., Psallidas, I., Porcel, J. M., Janssen, J., Froudarakis, M., Subotic, D., Astoul, P., Licht, P., Schmid, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00349-2018 · Cited by 316
Self-citation
Metadata
- Authors
- Rahman, N. M., Maskell, N. A., West, A., Teoh, R., Arnold, A., Mackinlay, C., Peckham, D., Davies, C. W. H., Ali, N., Kinnear, W., Bentley, A., Kahan, B. C., Wrightson, J. M., Davies, H. E., Hooper, C. E., Lee, Y. C. G., Hedley, E. L., Crosthwaite, N., Choo, L., Helm, E. J., Gleeson, F. V., Nunn, A. J., & Davies, R. J. O.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-08-11
- Volume
- 365
- Issue
- 6
- Pages
- 518-526
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2133581405
- Cited by
- 855
- References
- 18
- FWCI
- 31.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.